Trial Profile
Evaluation of USB005 in a Phase 1 Normal, Healthy Volunteer Ocular Safety and PK Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Aclerastide (Primary)
- Indications Wounds
- Focus Adverse reactions
- Sponsors US Biotest Inc
- 02 Apr 2019 Status changed from active, no longer recruiting to completed.
- 22 Jan 2019 Planned End Date changed from 1 Oct 2018 to 1 Feb 2019.
- 22 Jan 2019 Status changed from recruiting to active, no longer recruiting.